The HPV cellular transactivator Brn-3a can be used to predict cervical adenocarcinoma and squamous carcinoma precancer lesions in the developed and developing worlds
Ndisang, D. and Lorenzato, F. and Sindos, M. and Khan, A. and Singer, A. and Latchman, David S. (2009) The HPV cellular transactivator Brn-3a can be used to predict cervical adenocarcinoma and squamous carcinoma precancer lesions in the developed and developing worlds. Obstetrics and Gynecology International , ISSN 1687-9589.
4765.pdf - Published Version
Available under License Creative Commons Attribution.
Download (568kB) | Preview
The cellular transactivator Brn-3a has previously been shown to be expressed at elevated levels in the cervix of women with squamous cell carcinoma of the cervix (SCC) and to activate the expression of HPV E6 mRNA. In this study, we show that common and rare cervical precancer lesions, including those of adenocarcinoma (AC), which are usually difficult to diagnose using classical procedures, also expressed high levels of Brn-3a and can be diagnosed by measuring the levels of Brn-3a and E6 mRNAs.
|School:||Central Administration Departments > Master's Office|
|Depositing User:||Sarah Hall|
|Date Deposited:||14 Jun 2012 10:19|
|Last Modified:||17 Apr 2013 12:33|
Additional statistics are available via IRStats2.